Literature DB >> 31996440

Evaluation of the NG-Test MCR-1 Lateral Flow Assay and EDTA-Colistin Broth Disk Elution Methods To Detect Plasmid-Mediated Colistin Resistance among Gram-Negative Bacterial Isolates.

Alexander J Fenwick1, Yehudit Bergman1, Shawna Lewis1, Rebecca Yee1, Anne-Catrin Uhlemann2, Nicolynn Cole3, Peggy Kohner3, Carly Ordak4, Daniel A Green5, Audrey N Schuetz3,6, Romney Humphries7,8, Patricia J Simner9.   

Abstract

Plasmid-mediated colistin resistance (PMCR) is a global public health concern, given its ease of transmissibility. The purpose of this study was to evaluate two methods for the detection of PMCR from bacterial colonies: (i) the NG-Test MCR-1 lateral flow immunoassay (LFA; NG Biotech, Guipry, France) and (ii) the EDTA-colistin broth disk elution (EDTA-CBDE) screening test method. These methods were evaluated using a cohort of contemporary, clinical Gram-negative bacillus isolates from 3 U.S. academic medical centers (126 isolates of the Enterobacterales, 50 Pseudomonas aeruginosa isolates, and 50 Acinetobacter species isolates; 1 isolate was mcr positive) and 12 mcr-positive CDC-FDA Antibiotic Resistance (AR) Isolate Bank isolates for which reference broth microdilution colistin susceptibility results were available. Eleven (4.6%) isolates were strongly positive by the MCR-1 LFA, with an additional 8 (3.4%) isolates yielding faintly positive results. The positive percent agreement (PPA) and negative percent agreement (NPA) for MCR-1 detection were 100% and 96.1%, respectively. Upon repeat testing, only a single false-positive MCR-2 producer remained, as the isolates with initially faintly positive results were negative. The EDTA-CBDE screening method had an overall PPA and NPA of 100% and 94.3%, respectively. The NPA for the EDTA-CBDE method was slightly lower at 94.2% with Enterobacterales, whereas it was 96.0% with P. aeruginosa The MCR-1 LFA and EDTA-CBDE methods are both accurate and user-friendly methods for the detection of PMCR. Despite the rarity of PMCR among clinical isolates in the United States, these methods are valuable tools that may be implemented in public health and clinical microbiology laboratories to further discern the mechanism of resistance among colistin-resistant Gram-negative isolates and to detect PMCR for infection prevention and control purposes.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  MCR; colistin; methods; plasmid-mediated

Mesh:

Substances:

Year:  2020        PMID: 31996440      PMCID: PMC7098752          DOI: 10.1128/JCM.01823-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

Review 1.  Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.

Authors:  Fereshteh Ezadi; Abdollah Ardebili; Reza Mirnejad
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

2.  Dissemination of the mcr-1 colistin resistance gene.

Authors:  Michael R Mulvey; Laura F Mataseje; James Robertson; John H E Nash; Patrick Boerlin; Baldwin Toye; Rebecca Irwin; Roberto G Melano
Journal:  Lancet Infect Dis       Date:  2016-03       Impact factor: 25.071

3.  Detection of mcr-1 among Escherichia coli Clinical Isolates Collected Worldwide as Part of the SENTRY Antimicrobial Surveillance Program in 2014 and 2015.

Authors:  Mariana Castanheira; Michelle A Griffin; Lalitagauri M Deshpande; Rodrigo E Mendes; Ronald N Jones; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

4.  A simple phenotypic method for screening of MCR-1-mediated colistin resistance.

Authors:  M Coppi; A Cannatelli; A Antonelli; I Baccani; V Di Pilato; S Sennati; T Giani; G M Rossolini
Journal:  Clin Microbiol Infect       Date:  2017-08-19       Impact factor: 8.067

Review 5.  Towards Understanding MCR-like Colistin Resistance.

Authors:  Jian Sun; Huimin Zhang; Ya-Hong Liu; Youjun Feng
Journal:  Trends Microbiol       Date:  2018-03-07       Impact factor: 17.079

6.  Colistin antimicrobial susceptibility testing-can the slow and challenging be replaced by the rapid and convenient?

Authors:  C G Giske; G Kahlmeter
Journal:  Clin Microbiol Infect       Date:  2017-10-21       Impact factor: 8.067

7.  Two-Site Evaluation of the Colistin Broth Disk Elution Test To Determine Colistin In Vitro Activity against Gram-Negative Bacilli.

Authors:  Patricia J Simner; Yehudit Bergman; Marisol Trejo; Ava A Roberts; Remy Marayan; Tsigereda Tekle; Shelley Campeau; Abida Q Kazmi; Drew T Bell; Shawna Lewis; Pranita D Tamma; Romney Humphries; Janet A Hindler
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

8.  Identification of acquired antimicrobial resistance genes.

Authors:  Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen
Journal:  J Antimicrob Chemother       Date:  2012-07-10       Impact factor: 5.790

9.  Development and Multicentric Validation of a Lateral Flow Immunoassay for Rapid Detection of MCR-1-Producing Enterobacteriaceae.

Authors:  Hervé Volland; Laurent Dortet; Sandrine Bernabeu; Hervé Boutal; Marisa Haenni; Jean-Yves Madec; Frédéric Robin; Racha Beyrouthy; Thierry Naas; Stéphanie Simon
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

10.  Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program.

Authors:  Mark G Wise; Mark A Estabrook; Daniel F Sahm; Gregory G Stone; Krystyna M Kazmierczak
Journal:  PLoS One       Date:  2018-04-02       Impact factor: 3.240

View more
  1 in total

1.  Rapid high-resolution detection of colistin resistance in Gram-negative bacteria using flow cytometry: a comparison with broth microdilution, a commercial screening test and WGS.

Authors:  Oskar Ekelund; Marit Andrea Klokkhammer Hetland; Iren Høyland Löhr; Thomas Schön; Sofia Somajo
Journal:  J Antimicrob Chemother       Date:  2021-11-12       Impact factor: 5.790

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.